DaVita Inc. (DVA) News
Filter DVA News Items
DVA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DVA News Highlights
- DVA's 30 day story count now stands at 21.
- Over the past 10 days, the trend for DVA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- TOP, LZ and MPTI are the most mentioned tickers in articles about DVA.
Latest DVA News From Around the Web
Below are the latest news stories about DAVITA INC that investors may wish to consider to help them evaluate DVA as an investment opportunity.
Brookdale (BKD) Concludes Transactions to Extend Debt RepaymentBrookdale (BKD) completes two financing transactions to push its debt maturities until September 2025, thereby relieving it from the debt repayment burden for next year and focusing on core operations. |
3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your PortfolioZimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock. |
Three Reasons to Add Ecolab (ECL) Stock to Your PortfolioEcolab's (ECL) focus on R&D raises optimism about the stock. |
The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and HologicDaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog. |
DVA vs. CHE: Which Stock Is the Better Value Option?DVA vs. CHE: Which Stock Is the Better Value Option? |
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains. |
McKesson (MCK) Announces Availability of PNH's FDA-Approved DrugThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH. |
Three Reasons to Add DaVita (DVA) Stock to Your PortfolioDaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock. |
Should Value Investors Buy DaVita (DVA) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Here's Why You Should Retain Veeva Systems (VEEV) Stock NowVeeva Systems' (VEEV) strong product portfolio raises optimism about the stock. |